Ultragenyx Reports First Quarter 2014 Financial Results and Corporate Update
[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial results and corporate … more
View todays social media effects on RARE
View the latest stocks trending across Twitter. Click to view dashboard